United Therapeutics Corporation
US ˙ NasdaqGS ˙ US91307C1027

SecurityUTHR / United Therapeutics Corporation
InstitutionSei Investments Co
Latest Disclosed Ownership26,832 shares
Latest Disclosed Value $ 13,072,305
Sei Investments Co reports 30.21% decrease in ownership of UTHR / United Therapeutics Corporation

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 26,832 shares of United Therapeutics Corporation (US:UTHR) valued at $13,073,892 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 38,445 shares of United Therapeutics Corporation. This represents a change in shares of -30.21% during the quarter. The current value of the position is $14,743,379 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 26,832 -11,613 -30.21 13,072 -18.91 0.0129
2025-11-13 2025-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 38,445 -33,640 -46.67 16,121 -22.15 0.0173
2025-08-14 2025-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 72,085 14,289 24.72 20,710 16.24 0.0240
2025-05-14 2025-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 57,796 5,699 10.94 17,817 -3.08 0.0229
2025-05-13 2025-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 61,532 9,435 19,608 0.0213
2025-02-11 2024-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 52,097 -3,701 -6.63 18,383 -8.08 0.0236
2024-11-12 2024-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 55,798 19,349 53.09 19,999 72.23 0.0260
2024-08-13 2024-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 36,449 -808 -2.17 11,612 35.61 0.0165
2024-05-07 2024-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 37,257 1,149 3.18 8,562 7.82 0.0125
2024-02-14 2023-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 36,108 5,138 16.59 7,941 13.51 0.0127
2023-11-14 2023-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 30,970 3,548 12.94 6,996 15.62 0.0126
2023-08-11 2023-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 27,422 555 2.07 6,051 0.57 0.0106
2023-05-12 2023-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 26,867 3,254 13.78 6,017 -8.39 0.0112
2023-02-10 2022-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 23,613 -20,362 -46.30 6,568 -28.69 0.0146
2022-11-14 2022-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 43,975 -23,581 -34.91 9,210 -41.99 0.0205
2022-08-15 2022-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 67,556 7,863 13.17 15,877 47.19 0.0343
2022-05-13 2022-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 59,693 -2,327 -3.75 10,787 -20.16 0.0217
2022-02-14 2021-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 62,020 -6,791 -9.87 13,510 5.91 0.0253
2021-11-12 2021-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 68,811 11,728 20.55 12,756 24.62 0.0268
2021-08-06 2021-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 57,083 -1,840 -3.12 10,236 13.95 0.0227
2021-05-12 2021-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 58,923 654 1.12 8,983 1.47 0.0226
2021-02-08 2020-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 58,269 29,086 99.67 8,853 198.28 0.0229
2020-12-04 2020-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 29,183 966 3.42 2,968 -12.83 0.0086
2020-11-06 2020-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 29,705 1,488 3,021 7,273.8963
2020-08-17 2020-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 28,217 25,397 900.60 3,405 1,245.85 0.0106
2020-08-11 2020-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 27,106 24,286 3,264 8,853.7737
2020-05-14 2020-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,820 -155 -5.21 253 -0.78 0.0009
2020-02-06 2019-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 2,975 -215 -6.74 255 16.97 0.0008
2019-11-12 2019-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,190 -48 -1.48 218 -1.36 0.0006
2019-08-14 2019-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,238 -9,274 -74.12 221 -84.98 0.0007
2019-05-15 2019-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 12,512 717 6.08 1,471 13.07 0.0049
2019-02-13 2018-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 11,795 7,834 197.78 1,301 148.28 0.0046
2018-11-08 2018-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 3,961 -6,893 -63.51 524 -57.33 0.0019
2018-08-03 2018-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 10,854 1,184 12.24 1,228 12.97 0.0042
2018-05-11 2018-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 9,670 1,164 13.68 1,087 -13.66 0.0042
2018-02-08 2017-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 8,506 501 6.26 1,259 34.22 0.0044
2017-11-06 2017-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 8,005 2,107 35.72 938 22.45 0.0033
2017-07-31 2017-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 5,898 -24,340 -80.49 766 -81.29 0.0031
2017-05-05 2017-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 30,238 1,975 6.99 4,093 0.99 0.0179
2017-02-02 2016-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 28,263 7,278 34.68 4,053 63.63 0.0196
2016-11-04 2016-09-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 20,985 -2,231 -9.61 2,477 0.73 0.0126
2016-08-11 2016-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 23,216 2,083 9.86 2,459 4.46 0.0147
2016-05-10 2016-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 21,133 -1,281 -5.72 2,354 -32.95 0.0146
2016-02-03 2015-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 22,414 -52,782 -70.19 3,511 -64.42 0.0214
2015-11-02 2015-09-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 75,196 25,498 51.31 9,869 14.16 0.0906
2015-10-30 2015-09-30 13F DIREXION SHS ETF TR COM 91307C102 75,196 9,870
2015-08-07 2015-06-30 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 49,698 7,570 17.97 8,645 18.90 0.0782
2015-08-04 2015-06-30 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 49,698 7,570 8,645 0.0782
2015-05-14 2015-03-31 13F/A-1 UNITED THERAPEUTICS CORP DEL COM 91307C102 42,128 21,201 101.31 7,271 167.71 0.0631
2015-05-01 2015-03-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 42,128 7,271
2015-02-10 2014-12-31 13F UNITED THERAPEUTICS CORP DEL COM 91307C102 20,927 20,927 2,716 0.0240
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.